Boardroom Alpha
Meeting calendar
UAL · Annual meeting · Tuesday, May 19, 2026

United Airlines Holdings Inc

13 nominees · 4 ballot items.

Election of 11 directors; Ratification of Ernst & Young LLP as independent auditors; Advisory (non-binding) vote to approve named executive officers’ compensation (“Say-on-Pay”); Advisory vote on stockholder proposal regarding shareholders’ right to act by written consent.

Market cap
$38.6B
1Y TSR
+44.0%
Board grade
B
Record date
Mar 24, 2026
Filing
DEF 14A
Meeting concluded · May 19, 2026

Follow how the vote landed and what changed on United Airlines Holdings Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of 11 director nominees (Brewer, Freyre, Friend, Harford, Hooper, Isaacson, Kirby, Philip, Shapiro, Ward, Whitehurst) for a one-year term; ALPA and IAM nominees (Noyes, Johnsen) elected by preferred stock classes.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratification of appointment of Ernst & Young LLP as United’s independent registered public accounting firm for fiscal year ending December 31, 2026.

    More detail

    This management proposal asks shareholders to ratify the Audit Committee and Board’s selection of Ernst & Young LLP as United’s independent registered public accounting firm for fiscal 2026. Management seeks shareholder ratification as a matter of good governance and to obtain stockholder approval for the appointment. The Audit Committee recommended Ernst & Young after evaluating its historical performance, independence, expertise, and quality of communication; the committee also considers audit and non-audit fees and rotation of the lead partner. Ratification requires a majority of votes present and entitled to vote and because brokers have discretionary voting authority on this routine matter, brokers may vote if beneficial owners don't provide instructions. The Board’s recommendation is FOR, supported by the Audit Committee’s detailed oversight discussion in the proxy and a summary of fees and pre-approval policies. Failure to ratify would prompt the Audit Committee to reconsider the appointment, and the committee retains discretion to change auditors during the year if in the company’s interest.

  3. 3

    Advisory Vote to Approve Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Nonbinding advisory vote on approval of the compensation of named executive officers as disclosed in the proxy statement.

    More detail

    This management proposal asks shareholders to cast a nonbinding advisory vote to approve the Company’s executive compensation (Say-on-Pay) as disclosed in the proxy statement, including the CD&A and tables. Management seeks this annual advisory approval to gauge investor support for pay practices; the Board recommends FOR to demonstrate alignment between executive pay and company strategy. The compensation program emphasizes performance-based pay: short-term incentives linked to Adjusted EBITDAR margin, Net Promoter Score, and operational metrics; long-term incentives split between performance-based RSUs (Absolute Adjusted EPS, Relative Adjusted Pre-Tax Margin, strategic initiatives, and an $8 billion liquidity hurdle) and time-based RSUs; robust stock ownership guidelines; clawback policy; and no hedging or pledging. The Committee engaged an independent consultant, considered stockholder feedback (including concerns about 2024 retention awards), and retained the program with refinements. The vote is advisory and does not bind the Board, but the Board will consider results in future compensation decisions.

  4. 4

    Advisory Vote on Stockholder Proposal Regarding Shareholder Right to Act by Written Consent

    Shareholder — John CheveddenBoard: AGAINST

    Advisory (nonbinding) vote on a stockholder proposal to permit stockholders to act by written consent without restrictive ownership duration or holding-method requirements, enabling written consent rights and lower record dates.

    More detail

    This shareholder proposal seeks board action to adopt a written-consent right allowing shareholders to act outside of meetings by consent of the minimum number of votes that would be required to adopt the same action at a meeting where all shareholders were present and voting, removing United’s one-year ownership requirement and other procedural restrictions. The proponent, John Chevedden, argues the written-consent mechanism would increase shareholders’ ability to respond promptly to governance failures or management underperformance (for example, to replace directors) and contends United’s current one-year holding requirement for calling special meetings effectively prevents shareholders from using special meetings as a remedy. Management and the Board strongly oppose the proposal, arguing written consent lacks the transparency, safeguards and notification that meetings provide; that it risks enabling small or opportunistic interests to direct corporate action without adequate notice to all shareholders; and that written consent could be used to disenfranchise or surprise other owners. The Board emphasizes existing remedies, including the ability to call special meetings (with limited proxy access restrictions), robust shareholder engagement, annual director elections, proxy access, and prior shareholder votes rejecting similar proposals in 2015 and 2020. The Board recommends voting AGAINST, asserting the proposal is unnecessary and could harm long-term shareholder value by facilitating short-term opportunism. The proposal’s adoption would primarily alter corporate governance mechanics and could change the dynamics of shareholder influence by lowering procedural barriers to initiating corporate actions.

Director elections

Nominees on the ballot13

Not independent
Tenure on this board
6.2 yrs
Also a director at
Cvs Health Corp (CVS)
Independent
Tenure on this board
10.0 yrs
Also a director at
Strata Critical Medical Inc (SRTA)
Independent
Tenure on this board
10.4 yrs
Also a director at
Amplitude Inc (AMPL)Unity Software Inc (U)
Captain Brian Noyes
Not independent
Tenure on this board
New nominee
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC6.5%20,985,946$1.9B
2PRIMECAP MANAGEMENT CO/CA/4.9%15,750,610$1.5B
3Sanders Capital, LLC4.7%15,204,551$1.4B
4VANGUARD PORTFOLIO MANAGEMENT LLC4.3%14,067,839$1.3B
5STATE STREET CORP3.6%11,625,828$1.1B
6Capital World Investors3.4%11,112,611$1.0B
7FMR LLC3.3%10,854,451$999M
8BlackRock, Inc.3.0%9,730,952$896M
9GEODE CAPITAL MANAGEMENT, LLC2.5%8,263,715$770M
10Capital International Investors2.0%6,438,575$593M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the United Airlines Holdings Inc 2026 annual meeting?
United Airlines Holdings Inc (UAL) holds its 2026 annual shareholder meeting on Tuesday, May 19, 2026.
What is the record date for the United Airlines Holdings Inc 2026 meeting?
The record date for the United Airlines Holdings Inc 2026 meeting is Tuesday, March 24, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for United Airlines Holdings Inc's 2026 meeting?
The board is presenting 13 director nominees at the United Airlines Holdings Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the United Airlines Holdings Inc 2026 meeting?
Shareholders will vote on 4 proposals at the United Airlines Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer